| Leslie Baral, LCSW | |
|
11 Colburn Ct, Wayne, NJ 07470-8211 | |
| (973) 696-5668 | |
| (973) 305-8078 |
| Full Name | Leslie Baral |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 22 Years |
| Location | 11 Colburn Ct, Wayne, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285641159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SL05182600 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michael L. Sakowitz Ph.d., P.a, | 3779536404 | 8 |
News Archive
Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Our cells produce thousands of proteins but more than one-third of these proteins can fulfill their function only after migrating to the outside of the cell. While it is known that protein migration occurs with the help of various 'nanomotors' that push proteins out of the cell, little is known about their precise mechanical functioning.
› Verified 4 days ago
| Entity Name | Michael L. Sakowitz Ph.d., P.a, |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952464984 PECOS PAC ID: 3779536404 Enrollment ID: O20081206000021 |
News Archive
Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Our cells produce thousands of proteins but more than one-third of these proteins can fulfill their function only after migrating to the outside of the cell. While it is known that protein migration occurs with the help of various 'nanomotors' that push proteins out of the cell, little is known about their precise mechanical functioning.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie Baral, LCSW 11 Colburn Ct, Wayne, NJ 07470-8211 Ph: (973) 696-5668 | Leslie Baral, LCSW 11 Colburn Ct, Wayne, NJ 07470-8211 Ph: (973) 696-5668 |
News Archive
Apricus Biosciences, Inc. today announced that an additional analysis conducted on behalf of the Company has shown that MycoVa™ has successfully demonstrated 'non-inferiority' for the treatment of onychomycosis (commonly referred to as nail fungus), compared to the current standard of care in Europe for topical therapy, Loceryl®.
Merck today announced it has entered into a non-exclusive agreement with Bristol-Myers Squibb to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen consisting of Bristol-Myers Squibb's investigational NS5A replication complex inhibitor daclatasvir and Merck's investigational NS3/4A protease inhibitor MK-5172 for the treatment of chronic hepatitis C virus infection, genotype 1.
Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
Our cells produce thousands of proteins but more than one-third of these proteins can fulfill their function only after migrating to the outside of the cell. While it is known that protein migration occurs with the help of various 'nanomotors' that push proteins out of the cell, little is known about their precise mechanical functioning.
› Verified 4 days ago
Elyse Guli, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 122 Baldwin Ter, Wayne, NJ 07470 Phone: 201-887-1039 | |
Mrs. Luba Shagawat, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 642 Pines Lake Dr E, Wayne, NJ 07470 Phone: 973-831-1710 Fax: 973-831-1710 | |
Rajini Kurian, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 150 Hinchman Ave Ste 4, Wayne, NJ 07470 Phone: 973-595-6996 | |
Mr. David Brower, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7 Doig Rd Ste 2, Wayne, NJ 07470 Phone: 973-628-0234 Fax: 973-628-1955 | |
Mrs. Susan J Fecko, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 37 Balsam Rd, Wayne, NJ 07470 Phone: 973-839-6894 | |
Kayla Marie Blumetti, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1581 Route 23 Ste 2, Wayne, NJ 07470 Phone: 973-435-6252 | |
Gail Russo, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4 Timothy Rd, Wayne, NJ 07470 Phone: 518-573-1345 Fax: 973-406-7396 |